High‐dose cisplatin, etoposide, and cyclophosphamide with autologous stem cell reinfusion in patients with responsive metastatic or high‐risk primary breast cancer

G. Somlo, J. H. Doroshow, S. J. Forman, L. A. Leong, K. A. Margolin, R. J. Morgan, J. W. Raschko, S. A. Akman, C. Ahn, I. Sniecinski